Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Lung Neoplasms × pembrolizumab × Clear all

Sponsor

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 22 Carcinoma, Non-Small-Cell Lung 6 Melanoma 4 Uterine Cervical Neoplasms 3 Esophageal Neoplasms 3 Endometrial Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Renal Cell 3 Urothelial Cancer 2 Neoplasms 2 Mesothelioma 2 Cholangiocarcinoma 2 Bile Duct Neoplasms 2 Vulvar Neoplasms 1 Uveal Melanoma 1 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Parotid Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Microsatellite Instability 1

Interventions

selpercatinib 2 tremelimumab 1 repotrectinib 1 pralsetinib 1 encorafenib 1 durvalumab 1 ceritinib 1 capmatinib 1 brigatinib 1 binimetinib 1 Pemetrexed 1 Crizotinib 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡